Literature DB >> 29325978

Management of cardiac implantable electronic devices in the presence of left ventricular assist devices.

Valay Parikh1, Andrew Sauer1, Paul A Friedman2, Seth H Sheldon3.   

Abstract

Left ventricular assist devices (LVAD) are increasingly used in the management of patients with advanced heart failure. Many of these patients have or will be considered for a cardiac implantable electronic device (CIED) such as an implantable cardioverter-defibrillator or a cardiac resynchronization therapy device. Frequent interplay is often encountered due to the complexity of these devices and the underlying disease states. Proactive management strategies and an awareness of interactions may help reduce adverse events. Here we review the current literature, present management recommendations, and discuss potential future investigations for CIEDs in patients with LVADs.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced heart failure; Cardiac resynchronization therapy; Electromagnetic interference; Implantable cardioverter–defibrillator; Left ventricular assist device

Mesh:

Year:  2018        PMID: 29325978     DOI: 10.1016/j.hrthm.2018.01.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  2 in total

Review 1.  Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device.

Authors:  Jacinthe Boulet; Emmanuelle Massie; Blandine Mondésert; Yoan Lamarche; Michel Carrier; Anique Ducharme
Journal:  Curr Heart Fail Rep       Date:  2019-12

2.  Acute Hemodynamic Effects of Cardiac Resynchronization Therapy Versus Alternative Pacing Strategies in Patients With Left Ventricular Assist Devices.

Authors:  Brett Tomashitis; Catalin F Baicu; Ross A Butschek; Gregory R Jackson; Jeffrey Winterfield; Ryan J Tedford; Michael R Zile; Michael R Gold; Brian A Houston
Journal:  J Am Heart Assoc       Date:  2021-03-05       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.